TipRanks
Go Ultimate55% OFF

Genetec Corp. (4492) AI Stock Analysis

JP:4492

Genetec Corp.

(TSE/TYO:4492)

Select Model
Rating:60Neutral
Price Target:JPY 402.00â–²(13.88% Upside)
Action:reiterated
Date:08/19/26

The overall score is constrained by a significant divergence between strong profitability metrics and very weak cash flow generation, which is a major risk. This is compounded by a bearish technical trend. Mitigating factors include a rock-solid balance sheet and a highly attractive valuation with a low P/E and high dividend yield, which may provide a floor for the stock.

Positive Factors
Accelerating Revenue GrowthThe acceleration in revenue growth indicates strengthening demand and expanding business activity. If sustained, it can improve operating leverage, support continued investment in software offerings, and reinforce the company’s market position over the next several quarters.
Negative Factors
Sharp Cash-Flow DeteriorationThe latest collapse in operating and free cash flow, alongside very low cash conversion, raises concern that reported earnings are not translating into liquidity. Working-capital volatility or collection pressure could constrain reinvestment and financial resilience.

Genetec Corp. (4492) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%JP:4492-22.84%EWJ+16.91%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 4.09B
Dividend Yield
5.38%
Average Volume (3M)
25.00K
Price to Earnings (P/E)
8.2
Beta (1Y)
0.32
Revenue Growth
28.33%
EPS Growth
27.93%
Country
Japan
Employees
648
Sector
General
Sector Strength
55
Industry
Software - Application

Genetec Corp. Business Overview & Revenue Model

Company Description

Genetec Corporation is a Japanese company specializing in software development. Its operations are structured across three main business segments: Digital Solutions, Engineering Solutions, and Cocodayo. The Digital Solutions division focuses on creat...

How the Company Makes Money

null

Genetec Corp. Financial Statement Overview

Summary

Strong revenue growth (+28%) and a solid balance sheet (D/E 0.76, ROE 18.7%) are offset by a sharp decline in cash flow. Operating cash flow fell to just 1% of revenue, indicating poor cash conversion and a potential red flag for earnings quality.

Income Statement

70Positive

Balance Sheet

80Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue11.03B10.98B8.12B7.15B5.86B4.68B
Gross Profit4.18B4.15B3.27B2.91B2.32B1.96B
EBITDA1.07B1.06B849.75M775.92M259.62M226.31M
Net Income497.35M510.44M421.12M414.77M23.76M56.64M
Balance Sheet
Total Assets6.27B6.91B7.15B4.52B4.12B3.25B
Cash, Cash Equivalents and Short-Term Investments1.59B1.60B1.99B1.17B1.08B1.04B
Total Debt1.82B2.07B2.26B640.00M976.09M50.62M
Total Liabilities3.70B4.19B4.75B2.31B2.26B1.39B
Stockholders Equity2.57B2.73B2.40B2.21B1.87B1.86B
Cash Flow
Free Cash Flow046.85M384.76M578.85M-322.73M-117.29M
Operating Cash Flow0112.60M451.42M602.37M-223.12M-24.03M
Investing Cash Flow0-47.84M-388.73M-55.73M-439.20M-98.15M
Financing Cash Flow0-398.87M655.92M-410.02M714.93M-94.71M

Genetec Corp. Technical Analysis

Technical Analysis SentimentNegative
Last Price353.00

Price Trends

50DMA382.20Negative
100DMA388.14Negative
200DMA417.03Negative

Market Momentum

MACD-6.59Positive
RSI30.20Neutral
STOCH15.38Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4492, the sentiment is Negative. The current price of 353.00 is below the 20-day moving average (MA) of 376.75, below the 50-day MA of 382.20, and below the 200-day MA of 417.03, indicating a bearish trend. The MACD of -6.59 indicates Positive momentum. The RSI at 30.20 is Neutral, neither overbought nor oversold. The STOCH value of 15.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4492.

Genetec Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:4492 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3826JP:382682OutperformJPY 5.26B11.36―2.73%13.99%-36.97%
JP:4491JP:449175OutperformJPY 5.94B10.56―2.06%6.46%38.58%
JP:5033JP:503366NeutralJPY 7.96B47.67――7.04%-67.36%
JP:4397JP:439761NeutralJPY 6.01B15.80――23.50%2.72%
JP:4492JP:449260NeutralJPY 4.22B8.19―5.38%28.33%27.93%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:7527JP:752743NeutralJPY 4.87B145.16――-0.48%―

* General Sector Average

Performance Comparison

-25%0%25%50%JP:4492JP:3826JP:4397JP:4491JP:5033JP:7527Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4492 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4492Genetec Corp.353.00-115.02-24.58%
JP:3826System Integrator Corp.469.0016.853.73%
JP:4397TeamSpirit, Inc.357.00-150.00-29.59%
JP:4491Computer Management Co., Ltd.2892.00301.8611.65%
JP:5033Nulab Inc.1220.00457.0059.90%
JP:7527SystemSoft Corporation45.00-25.00-35.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 19, 2026